Showing results (121-130 of 10,339) with videos related to
Sort By:
Pageof 1,034
Annals of the Rheumatic Diseases|June 11, 2021
Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: a multicentre, parallel group, randomised controlled trialSiddharth Jain, Varun Dhir, Amita Aggarwal, et al.Annals of the Rheumatic Diseases|November 21, 2022
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisSytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, et al.Annals of the Rheumatic Diseases|January 1, 1985
Evidence against HLA and immunological dependence of disease outbreak in SLE. Immunological characterisation of identical twins clinically discordant for SLEE Soppi, J Eskola, A LehtonenAnnals of the Rheumatic Diseases|July 1, 1986
Thyroid disorders in systemic lupus erythematosusK L Goh, F WangAnnals of the Rheumatic Diseases|July 1, 1986
Response of acute cerebral lupus in childhood to pulse methylprednisolone in reduced dosageO Hanmer, D SaltissiAnnals of the Rheumatic Diseases|August 1, 1986
99mTc HMDP bone scanning in generalised nodal osteoarthritis. II. The four hour bone scan image predicts radiographic changeC W Hutton, E R Higgs, P C Jackson, et al.Annals of the Rheumatic Diseases|August 1, 1986
Systemic lupus erythematosus presenting as polymyalgia rheumatica in the elderlyC W Hutton, P J MaddisonAnnals of the Rheumatic Diseases|August 1, 1986
Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritisM Laakso, O Mutru, H Isomäki, et al.Annals of the Rheumatic Diseases|August 1, 1986
Amyloid deposits in the knee joint at autopsyC LadefogedAnnals of the Rheumatic Diseases|May 31, 2022
Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II studyClaire Daien, Marek Krogulec, Paul Gineste, et al.Pageof 1,034